What You Should Know
- The Trust Divide: A newly released report from EBSCO Clinical Decisions highlights a massive disconnect between clinical readiness and patient confidence regarding AI in healthcare. While 89% of clinicians believe AI for clinical decision support (AI-CDS) will ultimately lead to better patient outcomes, 64% of consumers would prefer to see a healthcare professional who does not use AI at all.
- General vs. Evidence-Based AI: Consumer skepticism is heavily tied to the type of AI being used. General AI tools (like ChatGPT or Gemini) are trained on broad, unvetted internet data and lack medical guardrails. Over half (54%) of consumers say their trust would actually decrease if a general AI tool were involved in their care.
Bridging the AI Trust Gap in Healthcare
In the rush to integrate artificial intelligence into the clinical workflow, the healthcare industry has largely focused on operational efficiency. But a newly released report from EBSCO Clinical Decisions, titled “The Clinician-Patient Trust Dynamic in the Era of AI-Powered Clinical Decision Support,“ reveals that the true value of AI isn’t just about saving time—it’s about saving the doctor-patient relationship.
The report uncovers a fascinating, somewhat alarming tension in modern medicine. Clinicians are overwhelmingly ready for AI, with 89% believing AI-CDS will lead to better patient outcomes and higher quality care. However, the patients sitting across from them are highly skeptical. A staggering 64% of consumers would prefer to see a healthcare professional who does not use AI at all.
ChatGPT vs. Evidence-Based AI
To bridge this trust gap, health systems must realize that neither clinicians nor patients view all AI equally.
General-purpose AI tools are trained on broad, largely unvetted internet data and entirely lack medical guardrails. Over half (54%) of consumers state that their trust would decrease if a general AI tool was involved in their care.
However, specialized AI-CDS tools are trained exclusively on peer-reviewed research and clinical guidelines, providing traceable, verifiable support. When this distinction is made clear, the skepticism vanishes. 80% of clinicians trust clinical guidance from evidence-based AI-CDS tools, and 66% of consumers say their trust in a medical recommendation would actually increase if a specialized AI tool were utilized.
Other key findings of the report include:
The Research Bottleneck: The current clinical workflow is highly inefficient. Today, 68% of clinicians spend an average of 3 to 6 hours per week manually searching for, reviewing, and synthesizing clinical evidence at the point of care.
The Efficiency Engine: AI-CDS drastically reduces this manual burden. 75% of clinicians who use AI-CDS report saving four minutes or more per patient encounter. Furthermore, nearly a quarter of users (23%) save 10 minutes or more per encounter.
The ‘Presence Payoff’: The ultimate value of AI-CDS is not merely operational efficiency; it is the reduction of cognitive load. 87% of clinicians agree that AI-CDS frees up mental energy. Importantly, 67% of consumers believe the time saved by AI will make providers more engaged and better communicators.
For more information about the report, visit https://more.ebsco.com/2026-AI-CDS-Report.html
